Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma × Drug Therapy × Clear all

Phase

Phase 2 6 Phase 1/2 3 Phase 2/3 2 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 15 Colorectal Neoplasms 13 Ovarian Neoplasms 10 Lung Neoplasms 10 Neoplasm Metastasis 9 Stomach Neoplasms 8 Nasopharyngeal Carcinoma 7 Leukemia, Myeloid, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Recurrence 5 Rectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Fallopian Tube Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Leukemia 4 Head and Neck Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Esophageal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Neoplasms by Site 2 Multiple Myeloma 2 Melanoma 2

Interventions

Doxorubicin 22 Ifosfamide 19 Radiotherapy 14 Vincristine 9 Etoposide 9 Filgrastim 8 Cyclophosphamide 8 Trabectedin 7 Dactinomycin 7 pazopanib 4 Cisplatin 4 Topotecan 3 Radiation 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Chemotherapy, Adjuvant 3 sargramostim 2 etoposide phosphate 2 eribulin 2 Observation 2 Methotrexate 2 Mesna 2 Imatinib Mesylate 2 Gemcitabine 2 Docetaxel 2 Dexrazoxane 2 Dacarbazine 2 trofosfamide 1 trioctyl phosphine oxide 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04307277 2026-02-11

CHIC-STS01

Institut Claudius Regaud

Phase 3 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡